HomePoliticsHome Sales Stumble as FDA Clears New Cancer Treatment
Politics

Home Sales Stumble as FDA Clears New Cancer Treatment

Existing home sales contracted throughout June as elevated mortgage rates and soaring property valuations locked out prospective buyers. Simultaneously, the medical landscape shifted for multiple myeloma patients, with the FDA authorizing a wearable injector for a Sanofi blood cancer treatment that eliminates the need for traditional intravenous infusions.

Home Sales Stumble as FDA Clears New Cancer Treatment

The housing sector remains a drag on broader economic momentum, with analysts projecting only a marginal contribution to growth for the current quarter. High borrowing costs continue to dictate the market, leaving many aspiring homeowners sidelined as affordability remains at historic lows.

In the aviation sector, the Commerce Department finalized its inquiry into imported aircraft and components. While officials identified potential national security risks, the administration opted against imposing new tariffs. This outcome followed an intense period of lobbying from domestic aviation stakeholders, highlighting the delicate balance required in ongoing trade negotiations.

Comments (0)

Leave a comment

No comments yet. Be the first!